CAS: 1020172-07-9 - Rebastinib

Fórmula: C₃₀H₂₈FN₇O₃

Sinónimos:

• N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea
• Dcc-2036

2-Pyridinecarboxamide, 4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-

CAS: 1020172-07-9

• Fórmula: C₃₀H₂₈FN₇O₃
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 553.5868

Rebastinib

CAS: 1020172-07-9

DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and …

• Fórmula: C₃₀H₂₈FN₇O₃
• Pureza: 99.53% - 99.84%
• Cor e Forma: Solid
• Peso molecular: 553.59

DCC 2036

CAS: 1020172-07-9

Inhibits multiple tyrosine kinases (Abl1, Src family kinases, Tie-2 and VEGFR-2)

• Fórmula: C₃₀H₂₈FN₇O₃
• Pureza: Min. 95%
• Cor e Forma: Powder
• Peso molecular: 553.59 g/mol

Rebastinib

CAS: 1020172-07-9

Applications Rebastinib shows the selectivity for growth inhibition of Bcr-Abl-positive cells by its marked inhibition …

• Fórmula: C₃₀H₂₈FN₇O₃
• Cor e Forma: Off-White Solid
• Peso molecular: 553.59